Evolution, Ayurveda, immunity, and preventive aspects for emerging infectious diseases such as COVID-19

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 86-93
Author(s):  
Dhirajsingh Sumersingh Rajput
Keyword(s):  
Infectious Diseases ◽  
Continuous Process ◽  
Physiological Mechanism ◽  
Emerging Infectious Diseases ◽  
Personal Hygiene ◽  
Breathing Exercise ◽  
Theory Of Evolution ◽  
Novel Coronavirus ◽  
Better Than ◽  
Living Being

Evolution is continuous process of changes in structural and physiological mechanism in living being. Microbes/pathogens can evolve naturally or artificially and become resistant to various medicines. Novel coronavirus is such evolved pathogen of coronavirus group. Enough strong immunity is needed to prevent or survive from COVID-19 pandemic. Ayurveda provides ways for evolving physiological responses to built immunity. Present work is brief attempt to increase insight in this filed.Present review was done based on simple theory of evolution, recent updates regarding prevention of COVID-19, Ayurveda aspect toward infectious diseases and Ayurveda ways towards prevention of infectious diseases with special reference to COVID-19. Person with impaired immunity is more susceptible for COVID-19 and thus immunity is an important preventing factor. Ayurveda Rasayana (rejuvanation) herbs, Yoga exercises, Pranayama (special breathing exercise), daily regimens and personal hygiene guidelines can be helpful strategies in controlling the spread of COVID-19.The preventive aspects of pandemic situations are narrated in Ayurveda with enough details. These ways need to be scientifically explored and refined for precision. As prevention is always better than cure hence Ayurveda ways can be considered for future strategies to avoid pandemics such as COVID-19.  There is great need of research on Ayurveda medicines on COVID-19 like diseases.

scholarly journals EMERGING INFECTIOUS DISEASES - A PERSPECTIVE

2020 ◽  
Vol 4 (9) ◽  
Author(s):  
Jayakumar K ◽  
Aneen Suresh ◽  
Sony Peter
Keyword(s):  
Infectious Diseases ◽  
National Security ◽  
Emerging Infectious Diseases ◽  
Wild Animals ◽  
Emerging Virus ◽  
Etiological Agents ◽  
Novel Coronavirus ◽  
Keywords Infection ◽  
The Impact

Infectious diseases continue to impose unpredictable burdens on global health and economies. Therefore, this has become a concern, even in terms of national security.  In this sense, the objective of the present article was to review the role of wild animals as reservoirs and/or dispersers of etiological agents of human infectious diseases in order to compile data on the main wild animals and etiological agents involved in zoonotic outbreaks. The zoonotic threat of these etiological agents and the impact on public health can be enormous as shown by the ongoing epidemic of 2019 novel coronavirus (2019- nCoV) infections. Keywords:  Infection, Emerging, Virus, Epedimiology, Pandemic, COVID

scholarly journals Pneumomediastinum in COVID-19 Patients

2020 ◽  
pp. 7-9
Author(s):  
Sebastián Campbell-Quintero ◽  
Santiago Campbell-Quintero ◽  
Santiago Campbell-Silva
Keyword(s):  
Public Health ◽  
Acute Respiratory Distress Syndrome ◽  
Severe Acute Respiratory Syndrome ◽  
Infectious Diseases ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Distress Syndrome ◽  
Emerging Infectious Diseases ◽  
Major Threat ◽  
Novel Coronavirus

Emerging infectious diseases, such as severe acute respiratory syndrome (SARS), present a major threat to public health. In December 2019, a novel coronavirus referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the causative agent of a respiratory syndrome named coronavirus disease 2019 (COVID-19). Since then, the pandemic has escalated. The spectrum of COVID-19 presentations ranges from mild self-limited flulike illness to severe viral pneumonia leading to acute respiratory distress syndrome that can be potentially fatal.

scholarly journals Scientometric trends for coronaviruses and other emerging viral infections

GigaScience ◽  
2020 ◽  
Vol 9 (8) ◽  
Author(s):  
Dima Kagan ◽  
Jacob Moran-Gilad ◽  
Michael Fire
Keyword(s):  
Infectious Diseases ◽  
Prior Knowledge ◽  
Viral Infections ◽  
Emerging Infectious Diseases ◽  
Full Understanding ◽  
The Past ◽  
Novel Coronavirus ◽  
Very High

Abstract Background COVID-19 is the most rapidly expanding coronavirus outbreak in the past 2 decades. To provide a swift response to a novel outbreak, prior knowledge from similar outbreaks is essential. Results Here, we study the volume of research conducted on previous coronavirus outbreaks, specifically SARS and MERS, relative to other infectious diseases by analyzing >35 million articles from the past 20 years. Our results demonstrate that previous coronavirus outbreaks have been understudied compared with other viruses. We also show that the research volume of emerging infectious diseases is very high after an outbreak and decreases drastically upon the containment of the disease. This can yield inadequate research and limited investment in gaining a full understanding of novel coronavirus management and prevention. Conclusions Independent of the outcome of the current COVID-19 outbreak, we believe that measures should be taken to encourage sustained research in the field.

scholarly journals Prevention is better than cure for emerging infectious diseases

BMJ ◽  
2014 ◽  
Vol 348 (feb21 1) ◽  
pp. g1499-g1499 ◽  
Author(s):  
D. L. Heymann ◽  
O. A. Dar
Keyword(s):  
Infectious Diseases ◽  
Emerging Infectious Diseases ◽  
Better Than

scholarly journals EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF 2019 NOVEL CORONA VIRUS: A REVIEW

2021 ◽  
pp. 1-6
Author(s):  
T SAI LAKSHMI SRIKALA ◽  
T PRAVEEN KUMAR
Keyword(s):  
Middle East ◽  
Clinical Characteristics ◽  
Treatment Strategies ◽  
Dromedary Camels ◽  
Wuhan City ◽  
The World ◽  
Novel Coronavirus ◽  
Country Office ◽  
Better Than ◽  
Living Being

Middle East Respiratory Syndrome (MERS), having a high demise rate, which radiate from the Middle East. Novel Coronavirus is the causative living being for MERS and (2019-nCoV) was recognized infection by Chinese experts on January 7. On December 31, 2019, the WHO China Country Office was educated regarding instances of pneumonia of obscure etiologic (obscure reason) identified in Wuhan City, Hubei Province of China. Besides, MERS-CoV first found in dromedary camels and in bats, people. Proof recommends that animals are acting as host for MERS-CoV and transmitting the malady to people. Till the finish of November 2019, an aggregate of 2494 lab instances of MERS, were recorded which incorporates 858 deaths around the world. At present, no drug or immunization is accessible for MERS. As we knew that prevention is better than cure, taking precautions before attacking of the disease is the best way of preventing disease. In this study, we discussed about the pathological aspects, treatment strategies, and precautions of the disease.

scholarly journals Thoughts on the naming of “COVID-19”

2020 ◽  
Vol 03 (01) ◽  
pp. 1-9
Author(s):  
Zhen Gao ◽  
Linwei Lu ◽  
Qin Bian ◽  
Jinfeng Wu ◽  
Feng Liu ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
Infectious Diseases ◽  
Nucleic Acids ◽  
Clinical Manifestations ◽  
Emerging Infectious Diseases ◽  
Organ Damage ◽  
Modern Medicine ◽  
Simple Type ◽  
Novel Coronavirus

Based on the naming of diseases in the history and the nomenclature of diseases, especially that of novel human infectious diseases, in traditional Chinese medicine (TCM) and modern medicine, we put forward the following suggestions for the naming and severity classification of “coronavirus disease 2019 (COVID-19)”: (1) Patients with only nucleic acids positive or nucleic acid positive as well as some of the symptoms but without any evidence of pneumonia should be diagnosed more generally such as “Novel coronavirus respiratory infection (NCRI)” or “Novel coronavirus infection (NCI)”. (2) The manifestations concerning pneumonia can be used as the main basis for the classification of the severity of the disease. For instance, those with only nucleic acids positive or nucleic acid positive as well as mild symptoms are mild, those with nucleic acid positive as well as symptoms like fever and cough are moderate, those with nucleic acid positive as well as pneumonia are severe, those with severe symptoms as well as respiratory failure and multiple organ damage are critical. (3) Also, those with infections and clinical manifestations but no pneumonia can be called simple type, and those with pneumonia can be called pneumonia type. (4) Under the current background of integrative medicine, the naming of newly emerging infectious diseases by TCM should be changed from an ambiguous concept to a clearly defined one. It may define the disease according to the etiology, pathogenesis, clinical manifestation or prognosis of the disease, redefine the original concept in TCM and discard the excessively broad part, or carry out the common naming between TCM and modern medicine based on the specific pathogen. (5) According to the nomenclature of diseases in TCM plus that in modern medicine, the NCI may be named “Jihai (2019) — Pestilence” (Ji Hài (2019) — Yì Lì) in TCM.

scholarly journals The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future

2020 ◽  
Vol 22 (2) ◽  
pp. 80-85 ◽  
Author(s):  
Jin-Yan Li ◽  
Zhi You ◽  
Qiong Wang ◽  
Zhi-Jian Zhou ◽  
Ye Qiu ◽  
...  
Keyword(s):  
Infectious Diseases ◽  
Emerging Infectious Diseases ◽  
The Future ◽  
Novel Coronavirus

scholarly journals Scientometric Trends for Coronaviruses and Other Emerging Viral Infections

2020 ◽  
Author(s):  
Dima Kagan ◽  
Jacob Moran-Gilad ◽  
Michael Fire
Keyword(s):  
Infectious Diseases ◽  
Prior Knowledge ◽  
Viral Infections ◽  
Emerging Infectious Diseases ◽  
Full Understanding ◽  
The Past ◽  
Novel Coronavirus ◽  
Very High

AbstractCOVID-19 is the most rapidly expanding coronavirus outbreak in the past two decades. To provide a swift response to a novel outbreak, prior knowledge from similar outbreaks is essential. Here, we study the volume of research conducted on previous coronavirus outbreaks, specifically SARS and MERS, relative to other infectious diseases by analyzing over 35 million papers from the last 20 years. Our results demonstrate that previous coronavirus outbreaks have been understudied compared to other viruses. We also show that the research volume of emerging infectious diseases is very high after an outbreak and drops drastically upon the containment of the disease. This can yield inadequate research and limited investment in gaining a full understanding of novel coronavirus management and prevention. Independent of the outcome of the current COVID-19 outbreak, we believe that measures should be taken to encourage sustained research in the field.

Sign in / Sign up

Export Citation Format

Share Document